Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05304819

PMCF Study of the AchilloCordPLUS System Implant Set for Acute Achilles Tendon Repair

Post-market Clinical Follow-up (PMCF) Study of the AchilloCordPLUS System Implant Set for Acute Achilles Tendon Repair

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
19 (actual)
Sponsor
Xiros Ltd · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a Post Market Clinical Follow Up Study in Orthopaedics, it will verify the long-term safety and performance of the device in the intended patient population, when indicated for the acute repair of the Achilles tendon. The Medical Device in this study AchilloCordPLUS is a Class IIb UKCA-Marked device manufactured by Xiros Ltd.

Detailed description

This is a Post Market Clinical Follow Up Study in Orthopaedics, it will verify the long-term safety and performance of the device in the intended patient population, when indicated for the acute repair of the Achilles tendon. The Medical Device in this study AchilloCordPLUS is a Class IIb UKCA-Marked device manufactured by Xiros Ltd. AchilloCordPLUS is a single-use device, indicated for patients with acute Achilles tendon ruptures. It is particularly suited to active patients where an extended period of postoperative immobilisation is undesirable. This study is a prospective, single-centre, consecutively recruited non-randomised study. The total length of the study is expected to be 3 years. This includes a recruitment period of approximately 12 months and a 2-year follow-up. This study has now closed to follow-up, with a recruitment of 19 participants. Follow up is at 2,4,6,8 and 12 weeks, 6 months and 1 and 2 years. All subjects treated with the AchilloCordPLUS for acute Achilles tendon repair will be consecutively recruited into the study.

Conditions

Interventions

TypeNameDescription
DEVICEAchilloCordPLUS™ System ImplantAchilloCordPLUS System Implant Set for Acute Achilles Tendon Repair

Timeline

Start date
2022-03-09
Primary completion
2024-06-13
Completion
2026-01-01
First posted
2022-03-31
Last updated
2025-01-31

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05304819. Inclusion in this directory is not an endorsement.